04/29/2024
4:04 PM | Y-mAbs Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
4:05 PM | Y-mAbs Therapeutics (Filer)
| Form ARS | |
04/29/2024
4:09 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
4:09 PM | Paradigm Biocapital Advisors LP (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G | |
03/14/2024
4:01 PM | TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:17 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
5:17 AM | TAGLIAFERRI MARY (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
03/07/2024
4:02 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:49 PM | Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
3:40 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:05 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
5:05 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
4:04 PM | Y-mAbs Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2024
2:59 PM | ACORN BIOVENTURES, L.P. (Filed by)
Y-mAbs Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
4:54 PM | Lund-Hansen Torben (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:56 PM | Wilms Joris (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:58 PM | Lisby Steen (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:00 PM | Smith Susan Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:02 PM | Rajah Vignesh (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:48 PM | Kruse Bo (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
4:52 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
5:45 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2023
3:15 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
6:40 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:40 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
7:27 AM | WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:26 AM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
4:25 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
4:25 PM | WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:14 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:15 PM | WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
4:14 PM | WG Biotech ApS (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2023
4:15 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
3:47 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
4:15 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/08/2023
4:16 PM | Rossi Michael J (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
4:19 PM | Gad Thomas (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:09 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
8:00 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
5:00 PM | TYAGI ASHU (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:00 PM | HEALY JAMES (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The 2024 Gold Rush: Unleashing Market Potential (Ad) Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. |
06/09/2023
5:01 PM | GILL DAVID N (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:02 PM | Ber Gerard (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:04 PM | Wedell-Wedellsborg Johan (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:05 PM | Hamill Laura (Reporting)
Y-mAbs Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:30 PM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
8:41 AM | Y-mAbs Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2023
11:15 PM | Y-mAbs Therapeutics (Filer)
| Form EFFECT | |
